Promising efficacy data for next-gen FGFR inhibitor tinengotinib in CCA Presented ByDr Milind Javle, MD Anderson Cancer Center, TX, USA TrialPhase 2 ConferenceASCO GI 2024 TypeNews article 13 February 2024 13:05